SL Green Realty Corp. announced the sale of 110 Greene Street to Natora Group for $226 million, closing Q4 2026.
The R&D Day will review NVG-291, its clinical data, therapeutic potential, and the Phase 3 RESTORE study design. The R&D Day ...
Helus Pharma's CEO will join a fireside chat at the H.C. Wainwright Conference on September 14, 2026.
Fate Therapeutics announces clinical and preclinical data on CAR T-cell therapies at CCR-West meeting, highlighting safety ...
The study shows that elraglusib combined with RAS inhibitors improves anti-tumor activity in pancreatic cancer models.
Context Therapeutics initiates a Phase 1 trial for CT-202, targeting Nectin-4 in solid tumors. Initial data expected in 2027.
Gilat Satellite Networks secures a $32 million order from the U.S. Department of War for advanced satellite communications ...
Lightbridge Corporation has secured access to the Idaho National Laboratory's Advanced Test Reactor loop testing facility, a ...
Perma-Pipe International Holdings Inc. (PPIH) reported fiscal second-quarter 2026 net sales of $59.6 million, up 24.4% from ...
Core & Main (NYSE: CNM) reported fiscal 2026 second-quarter net sales of $2.145 billion, up 2.5% from a year earlier, and net income of $150 million, up 6.4%. Basic and diluted earnings per share were ...
XCharge has regained compliance with Nasdaq's minimum bid price requirement, closing the deficiency matter.
Satellos Bioscience announces the INN designation "forazapadin" for its muscle regeneration drug, targeting Duchenne muscular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results